Brian Druker Created 2026-10-24 Updated 2026-11-05
Researcher in targeted cancer therapy. Druker and collaborators investigated selective inhibition of the Abl tyrosine kinase in BCR-ABL-positive cells, connecting a molecular driver of disease with an experimentally targeted drug mechanism.[ref]
Portrait of Brian Druker
. Rubenstein. CC BY 2.0, via Wikimedia Commons. Source.